Explore more publications!

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on December 5, 2025

NBCI Announce The 25 Most Effective Christian Biblical Preachers of 2025-2026 in the Black Preaching Tradition
Image Diplomacy becomes Bloomberg Media's exclusive commercial partner in EastAfrica & Mauritius
Good Dad Act Committee Highlights Kentucky & Florida Paternity Laws & Reaffirms - 2024 Legislative Proposal to Kentucky
Carziqo’s Autonomous Ride-Hailing Investment Model Sparks a Global Wave
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
Emerita Receives Official Court Resolution in Aznalcóllar Trial
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
XT Exchange Rolls Out Soccer Prediction Cycle 2 With a $3,000,000 Reward Pool and 20% XScore Rebate
GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirasol Announces Change in Chief Financial Officer
Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MEXC Reports 1,329% Average Peak Return Across Top New Tokens in November
Sapu Nano Announce Deciparticle™ Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions